Seeing Is Believing
CRGX is currently covered by 7 analysts with an average price target of $10.84. This is a potential upside of $6.65 (158.71%) from yesterday's end of day stock price of $4.19.
CARGO Therapeutics, Common Stock's activity chart (see below) currently has 0 price targets and 20 ratings on display. The stock rating distribution of CRGX is 65% BUY, 30% HOLD and 5% SELL.
Analysts average stock forecasts to be materialized ratio is 27.78% with an average time for these price targets to be met of 26.5 days.
Highest price target for CRGX is $7, Lowest price target is $3, average price target is $4.67.
Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 30-Jan-2025. First documented stock forecast 05-Dec-2023.
Currently out of the existing stock ratings of CRGX, 13 are a BUY (65%), 6 are a HOLD (30%), 1 are a SELL (5%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$33
4 months 28 days ago
(30-Jan-2025)
0/3 (0%)
$17 (106.25%)
Hold
$7
$2.73 (63.93%)
$32
4 months 28 days ago
(30-Jan-2025)
0/3 (0%)
$3.61 (106.49%)
Hold
$4
$-0.27 (-6.32%)
$34
4 months 28 days ago
(30-Jan-2025)
1/3 (33.33%)
$0.61 (17.99%)
39
Sell
$30
4 months 28 days ago
(30-Jan-2025)
2/2 (100%)
$7.09 (30.95%)
27
Hold
$3
$-1.27 (-29.74%)
$32
4 months 28 days ago
(30-Jan-2025)
1/3 (33.33%)
$-0.39 (-11.50%)
93
What is CRGX (CARGO Therapeutics, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on CRGX (CARGO Therapeutics, Common Stock) with a proven track record?
Which analyst has the current lower performing score on CRGX (CARGO Therapeutics, Common Stock) with a proven track record?
Which analyst has the most public recommendations on CRGX (CARGO Therapeutics, Common Stock)?
Which analyst is the currently most bullish on CRGX (CARGO Therapeutics, Common Stock)?
Which analyst is the currently most reserved on CRGX (CARGO Therapeutics, Common Stock)?